A Swedish analysis has identified 5 diabetic "clusters" that could aid diagnosis and individualize treatment. Scroll through our quick slideshow for details.
Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis
Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.
Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use
This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.
New Cancerguard Blood Test for Multi-Cancer Early Detection Now Available in the US
Exact Sciences launches Cancerguard™, a groundbreaking blood test for early cancer detection, aiming to transform cancer screening and save lives.
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks
This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.
First Generic GLP-1 RA Approved for Weight Management in the US: Daily Dose
Your daily dose of the clinical news you may have missed.
Positive Topline Results on Long-Term Safety Reported for Rocatinlimab in Moderate to Severe Atopic Dermatitis
Rocatinlimab offers promise as a novel T-cell rebalancing therapy that targets the OX40 receptor, with maintenance dosing as infrequently as every 8 weeks.